Default company panoramic image
Cbbe0a02 9061 4746 9772 0f95595a571b

PathoVacs

Speeding vaccine development. PathoVacs lowers cost, speeds up identification of protein antigens with potential for universal protection

  • Stage Product In Development
  • Industry Biotechnology
  • Location Ames, IA, USA
  • Currency USD
  • Founded September 2009
  • Employees 1
  • Website pathovacs.com

Company Summary

PathoVacs uses a very clever and innovative technology for rapid discovery of protein antigens for universal vaccines against infectious agents that cause disease both in humans and livestock. Potenial customers include established biologics companies for antigen discovery services, and sub-licensees, and major vaccines companies for partnered development of proprietary vaccines developed to the experimental vaccine stage "in house."

Team

  • Default avatar
    Chuck Soponis
    CEO

    Chuck Soponis, has led nine startup companies, achieving two IPO and three acquisition exits.

  • Default avatar
    Manohar John
    Chief Scientific Officer

    Dr. Manohar John, is the Founder of Pathovacs, and the inventor of the PELS antigen discovery technology. Dr. John is extensively experienced in
    preclinical bacterial vaccine development acquired both as faculty at Massachusetts General Hospital and Harvard Medical School, and as Director of Biomarker Discovery in industry.

Advisors

  • Default avatar
    Nyemaster
    Lawyer
    Unconfirmed
    Default avatar
    LWB
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Manohar John, Founder
    Unconfirmed
    Default avatar
    Iowa Department of Economic Development
    Unconfirmed